全文获取类型
收费全文 | 123381篇 |
免费 | 8054篇 |
国内免费 | 535篇 |
专业分类
耳鼻咽喉 | 1313篇 |
儿科学 | 3635篇 |
妇产科学 | 2062篇 |
基础医学 | 16387篇 |
口腔科学 | 2207篇 |
临床医学 | 12196篇 |
内科学 | 26123篇 |
皮肤病学 | 1490篇 |
神经病学 | 11968篇 |
特种医学 | 3817篇 |
外国民族医学 | 1篇 |
外科学 | 17707篇 |
综合类 | 1658篇 |
现状与发展 | 1篇 |
一般理论 | 156篇 |
预防医学 | 10746篇 |
眼科学 | 3319篇 |
药学 | 8727篇 |
1篇 | |
中国医学 | 278篇 |
肿瘤学 | 8178篇 |
出版年
2023年 | 609篇 |
2022年 | 1076篇 |
2021年 | 2373篇 |
2020年 | 1410篇 |
2019年 | 2404篇 |
2018年 | 2804篇 |
2017年 | 2041篇 |
2016年 | 2380篇 |
2015年 | 2743篇 |
2014年 | 3960篇 |
2013年 | 5559篇 |
2012年 | 8474篇 |
2011年 | 9103篇 |
2010年 | 4969篇 |
2009年 | 4635篇 |
2008年 | 8030篇 |
2007年 | 8521篇 |
2006年 | 8081篇 |
2005年 | 8128篇 |
2004年 | 7673篇 |
2003年 | 7076篇 |
2002年 | 6819篇 |
2001年 | 1193篇 |
2000年 | 890篇 |
1999年 | 1228篇 |
1998年 | 1452篇 |
1997年 | 1224篇 |
1996年 | 949篇 |
1995年 | 946篇 |
1994年 | 799篇 |
1993年 | 786篇 |
1992年 | 664篇 |
1991年 | 608篇 |
1990年 | 540篇 |
1989年 | 501篇 |
1988年 | 502篇 |
1987年 | 484篇 |
1986年 | 419篇 |
1985年 | 497篇 |
1984年 | 562篇 |
1983年 | 522篇 |
1982年 | 697篇 |
1981年 | 610篇 |
1980年 | 534篇 |
1979年 | 368篇 |
1978年 | 347篇 |
1977年 | 348篇 |
1976年 | 291篇 |
1975年 | 272篇 |
1974年 | 279篇 |
排序方式: 共有10000条查询结果,搜索用时 0 毫秒
101.
102.
Dr. Andrew G. Bostom M.D. Dr. Anne L. Hume Pharm.D. Dr. Charles B. Eaton M.D. Dr. Joseph P. Laurino Ph.D. Ms. Lisa R. Yanek B.A. Ms. Mary S. Regan B.S. Mr. William H. McQuade M.P.H. Dr. Wendy Y. Craig Ph.D. Ms. Gayle Perrone M.B.A. Dr. Paul F. Jacques Sc.D. 《Pharmacotherapy》1995,15(4):458-464
Study Objective . To determine the efficacy of high-dose ascorbate supplementation in lowering lipoprotein(a) [Lp(a)] levels in patients with premature coronary heart disease (CHD). Design . Randomized, double-blind, placebo-controlled trial. Setting . Outpatient clinic. Patients . Forty-four patients with documented premature CHD. defined as confirmed myocardial infarction and/or angiographically determined stenosis of 50% or greater in at least one major coronary artery before age 60 years. Interventions . Patients were block randomized on the basis of age, gender, and screening Lp(a) concentrations to receive ascorbate 4.5 g/day or placebo for 12 weeks. Measurements and Main Results . High-dose ascorbate was well tolerated and produced a marked elevation in mean plasma ascorbate levels (+1.2 mg/dl; p<0.001). Multiple linear regression analysis revealed no significant effect of supplementation on postintervention Lp(a) levels (p=0.39) in a model that included treatment group assignment, and baseline Lp(a) levels. Conclusions . Our findings do not support a clinically important lowering effect of high-dose ascorbate on plasma Lp(a) in patients with premature CHD. 相似文献
103.
Paul Fockens MD Carin G. Manshanden MD J.Jan B. van Lanschot MD Hugo Obertop MD Guido N.J. Tytgat MD 《Gastrointestinal endoscopy》1997,46(6):487-491
Background: Half of the patients who undergo surgery for cancer of the esophagus or gastric cardia present with recurrent disease within 2 years after the operation. We investigated the value of endosonography for the early detection of recurrent disease. Methods: Forty-three patients entered a follow-up protocol in which endosonography was performed every 6 months within the first 2 years after resection. Results: During 16 of a total of 66 examinations, suspicious abnormalities were found. In three patients free fluid was seen, but recurrence could not be confirmed during follow-up. In eight patients suspicious lymph nodes were seen; six died within 6 months, one was alive with a proven recurrence at 6 months, and one was alive without recurrence at 22 months. In five patients focal wall-thickening or a mass was seen; three died within 6 months, and two were alive with a proven recurrence at 2 and 5 months. After exclusion of free fluid, the positive predictive value of abnormalities on endoscopic ultrasonography (EUS) was 92%. Conclusions: Endosonography, performed at 6-month intervals after resection of cancer of the esophagus or gastric cardia, is accurate in the early detection of locoregional recurrent disease. Two thirds of the patients were still without symptoms when the recurrence was found. (Gastrointest Endosc 1997;46:487-91.) 相似文献
104.
105.
Paul R. Finley R. Jane Williams Carla Fletcher 《Journal of clinical laboratory analysis》1988,2(4):249-255
We have devised assays to detect both circulating alloantibodies to platelets (indirect assay) and platelet-association IgG and IgM (direct assay) using a flow cytometric technique. A variety of patients with immune thrombocytopenia were studied. Employment of a confocal lens in the flow cytometer increased the discrimination power of the instrument. Patients with autoimmune thrombocytopenia (idiopathic thrombocytic purpura [ITP], systemic lupus erythematosus (SLE), lymphoma, leukemia, and drug-induced thrombocytopenia showed a significant increase in platelet-associated antibody. Circulating antibodies to platelets (alloantibodies) were demonstrated in cases of platelet refractoriness and neonatal isoimmune purpura. Day-today precision of the assays ranged from 3% to 6% (coefficient of variation). No interference was shown in the presence of hemoglobin (5 g/L), triglycerides (10 g/L), or polyclonal and monoclonal immunoglobulinemia (50 g/L: IgG, IgA, IgM). The sensitivity of the direct assay was 500 attograms of IgG or IgM platelet. 相似文献
106.
Clanton C. Shipp Paul S. Berger Manya S. Deehr Bess Dawson-Hughes M.D. 《Calcified tissue international》1988,42(5):287-292
Summary Precision of dual-photon absorptiometry (DPA) measurements was determined in a lumbar spine phantom and in humans. Approximately
half of the measurements were made before and half after a153gadolinium source change. The phantom was measured with different amounts of acrylic, which simulates human soft tissue, in
order to evaluate the influence of body thickness on bone mineral density (BMD). Results of scans analyzed with two software
versions from Lunar Radiation Corp., the widely used 08B and a prototype 08C, are compared. DPA with a cold source significantly
overestimated BMD in the phantom in the presence of large amounts (more than 25 cm) of soft tissue equivalent with version
08B but not with the newer version 08C. Similiarly, in nine subjects, there was a significant decrease in spine BMD after
a source change when scans were analyzed with version 08B (mean difference 0.026 g/cm2,P=0.002) but not with 08C (0.01 g/cm2,P=0.234). No systematic effect of source change on femoral BMD measurements was observed. The SD of the mean difference of
two measurements of the nine subjects was 0.019 g/cm2 (1.6% of the mean value) for the spine with software version 08B and 0.024 g/cm2 (2.0%) with version 08C, 0.03 g/cm2 (3.3%) for the femur neck, 0.03 g/cm2 (4.0%) for the greater trochanter, and 0.04 g/cm2 (4.9%) for Ward's triangle region of the proximal femur. The spine phanton was scanned on two other commercial bone densitometers
in order to assess inter-instrument variation. Phantom measurements of L2-4 BMD made on two Lunar Radiation Corp model DP3
scanners which differed by 2% were 10 and 12% higher than those with a Norland Corp. model 2600 scanner. 相似文献
107.
Paul G. Egland Dale A. Pelletier Marilyn Dispensa Jane Gibson Caroline S. Harwood 《Proceedings of the National Academy of Sciences of the United States of America》1997,94(12):6484-6489
A reductive benzoate pathway is the central conduit for the anaerobic biodegradation of aromatic pollutants and lignin monomers. Benzene ring reduction requires a large input of energy and this metabolic capability has, so far, been reported only in bacteria. To determine the molecular basis for this environmentally important process, we cloned and analyzed genes required for the anaerobic degradation of benzoate and related compounds from the phototrophic bacterium, Rhodopseudomonas palustris. A cluster of 24 genes was identified that includes twelve genes likely to be involved in anaerobic benzoate degradation and additional genes that convert the related compounds 4-hydroxybenzoate and cyclohexanecarboxylate to benzoyl-CoA. Genes encoding benzoyl-CoA reductase, a novel enzyme able to overcome the resonance stability of the aromatic ring, were identified by directed mutagenesis. The gene encoding the ring-cleavage enzyme, 2-ketocyclohexanecarboxyl-CoA hydrolase, was identified by assaying the enzymatic activity of the protein expressed in Escherichia coli. Physiological data and DNA sequence analyses indicate that the benzoate pathway consists of unusual enzymes for ring reduction and cleavage interposed among enzymes homologous to those catalyzing fatty acid degradation. The cloned genes should be useful as probes to identify benzoate degradation genes from other metabolically distinct groups of anaerobic bacteria, such as denitrifying bacteria and sulfate-reducing bacteria. 相似文献
108.
Paul Saenger Kenneth M. Attie Joan DiMartino-Nardi Richard N. Fine 《Pediatric nephrology (Berlin, Germany)》1996,10(3):261-263
Carbohydrate metabolism was evaluated by fasting and postprandial glucose, insulin, and hemoglobin (Hb)A1c levels in children with chronic renal insufficiency and various other growth disorders treated with growth hormone. Mean fasting and postprandial glucose remained unchanged throughout the 5-year study period in all four study groups. Median fasting insulin levels rose from lownormal levels into the normal range after 5 years of growth hormone. Average fasting insulin level after 5 years was 10 mU/l. Median postprandial insulin values also rose, yet remained within the normal range at the 5-year mark. Mean Hb A1c levels remained within low to middle end of the normal range in the patients with growth hormone deficiency, Turner syndrome, and idiopathic short stature. Mean Hb A1c levels at the 5 years were slightly elevated to 6.3% for the patients with chronic renal insufficiency. 相似文献
109.
110.